Inhaled NO restores lung structure in eNOS-deficient mice recovering from neonatal hypoxia

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 291, Issue 1, 2006, Pages

  Balasubramaniam, Vivek ^a,b   Maxey, Anne M ^a   Morgan, Danielle B ^a   Markham, Neil E ^a   Abman, Steven H ^a  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Endothelial nitric oxide; Nitric oxide

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; GROWTH CURVE; HETEROZYGOSITY; HYPOBARISM; LUNG ALVEOLUS CELL; LUNG STRUCTURE; MORPHOMETRICS; MOUSE; NEWBORN HYPOXIA; NONHUMAN; PRIORITY JOURNAL; STAINING;

ADMINISTRATION, INHALATION; AIR; ANIMALS; ANIMALS, NEWBORN; ANOXIA; ANTIGENS, CD31; BODY WEIGHT; FEMALE; MALE; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PULMONARY ALVEOLI; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 33745686054     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00395.2005     Document Type: Article

References (56)

1. Abman S. Pulmonary hypertension in chronic lung disease of infancy: pathogenesis, pathophysiology, and treatment. In: Chronic Lung Disease in Early Infancy, edited by Bland RD and Coalson JJ. New York: Dekker, 1999, p. 619-668.
2. Afshar S, Gibson LL, Yuhanna IS, Sherman TS, Kerecman JD, Grubb PH, Yoder BA, McCurnin DC, and Shaul PW. Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease. Am J Physiol Lung Cell Mol Physiol 284: L749-L758, 2003.
3. Albertine KH, Jones GP, Starcher BC, Bohnsack JF, Davis PL, Cho SC, Carlton DP, and Bland RD. Chronic lung injury in preterm lambs. Disordered respiratory tract development. Am J Respir Crit Care Med 159: 945-958, 1999.
4. Balasubramaniam V, Le Cras TD, Ivy DD, Grover TR, Kinsella JP, and Abman SH. Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 284: L826-L833, 2003.
5. Balasubramaniam V, Tang JR, Maxey A, Plopper CG, and Abman SH. Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse. Am J Physiol Lung Cell Mol Physiol 284: L964-L971, 2003.
6. Baldwin HS. Early embryonic vascular development. Cardiovasc Res 31: E34-E45, 1996.
7. Bland RD, Albertine KH, Carlton DP, Kullama L, Davis P, Cho SC, Kim BI, Dahl M, and Tabatabaei N. Chronic lung injury in preterm lambs: abnormalities of the pulmonary circulation and lung fluid balance. Pediatr Res 48: 64-74, 2000.
8. Bland RD, Albertine KH, Carlton DP, and MacRitchie AJ. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med 172: 899-906, 2005.
9. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
10. Burri P. Structural aspects of prenatal and postnatal development and growth for the lung. In: Lung Growth and Development, edited by McDonald JA. New York: Dekker, 1997, p. 1-35.
11. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-395, 2000.
12. Coalson JJ. Pathology of chronic lung disease of early infancy. In: Chronic Lung Disease in Early Infancy, edited by Bland RD and Coalson JJ. New York: Dekker, 1999, p. 85-124.
13. Coalson JJ, Winter VT, Siler-Khodr T, and Yoder BA. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 160: 1333-1346, 1999.
14. Cooney TP and Thurlbeck WM. The radial alveolar count method of Emery and Mithal: a reappraisal 2: intrauterine and early postnatal lung growth. Thorax 37: 580-583, 1982.
15. Dimmeler S, Dernbach E, and Zeiher AM. Phosphorylation of the endothelial nitric oxide synthase at Ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett 477: 258-262, 2000.
16. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, and Jain RK. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98: 2604-2609, 2001.
17. Gebb SA and Shannon JM. Tissue interactions mediate early events in pulmonary vasculogenesis. Dev Dyn 217: 159-169, 2000.
18. Han RN, Babaei S, Robb M, Lee T, Ridsdale R, Ackerley C, Post M, and Stewart DJ. Defective lung vascular development and fatal respiratory distress in endothelial NO synthase-deficient mice: a model of alveolar capillary dysplasia? Circ Res 94: 1115-1123, 2004.
19. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, and Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242, 1995.
20. Husain AN, Siddiqui NH, and Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 29: 710-717, 1998.
21. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, and Abman SH. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 279: L600-L607, 2000.
22. Jobe AH and Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163: 1723-1729, 2001.
23. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 46: 641-643, 1999.
24. Kroll J and Waltenberger J. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun 252: 743-746, 1998.
25. Le Cras TD, Markham NE, Tuder RM, Voelkel NF, and Abman SH. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol 283: L555-L562, 2002.
26. Leuwerke SM, Kaza AK, Tribble CG, Kron IL, and Laubach VE. Inhibition of compensatory lung growth in endothelial nitric oxide synthase-deficient mice. Am J Physiol Lung Cell Mol Physiol 282: L1272-L1278, 2002.
27. Lin YJ, Markham NE, Balasubramaniam V, Tang JR, Maxey A, Kinsella JP, and Abman SH. Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res 58: 22-29, 2005.
28. MacRitchie AN, Albertine KH, Sun J, Lei PS, Jensen SC, Freestone AA, Clair PM, Dahl MJ, Godfrey EA, Carlton DP, and Bland RD. Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs. Am J Physiol Lung Cell Mol Physiol 281: L1011-L1020, 2001.
29. Massaro D and Massaro GD. Pulmonary alveoli: formation, the "call for oxygen," and other regulators. Am J Physiol Lung Cell Mol Physiol 282: L345-L358, 2002.
30. 2 and a critical period. Am J Physiol Lung Cell Mol Physiol 258: L321-L327, 1990.
31. 2 alters postnatal development of lung alveoli. Am J Physiol Lung Cell Mol Physiol 257: L221-L225, 1989.
32. McCurnin DC, Pierce RA, Chang LY, Gibson LL, Osborne-Lawrence S, Yoder BA, Kerecman JD, Albertine KH, Winter VT, Coalson JJ, Crapo JD, Grubb PH, and Shaul PW. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol 288: L450-L459, 2005.
33. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, and Isner JM. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101: 2567-2578, 1998.
34. Neufeld G, Cohen T, Gengrinovitch S, and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22, 1999.
35. Northway WH Jr, Rosan RC, and Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276: 357-368, 1967.
36. Pierce RA, Albertine KH, Starcher BC, Bohnsack JF, Carlton DP, and Bland RD. Chronic lung injury in preterm lambs: disordered pulmonary elastin deposition. Am J Physiol Lung Cell Mol Physiol 272: L452-L460, 1997.
37. Randell SH, Mercer RR, and Young SL. Neonatal hyperoxia alters the pulmonary alveolar and capillary structure of 40-day-old rats. Am J Pathol 136: 1259-1266, 1990.
38. Randell SH, Mercer RR, and Young SL. Postnatal growth of pulmonary acini and alveoli in normal and oxygen-exposed rats studied by serial section reconstructions. Am J Anat 186: 55-68, 1989.
39. Risau W. Mechanisms of angiogenesis. Nature 386: 671-674, 1997.
40. Shaffer SG, O'Neill D, Bradt SK, and Thibeault DW. Chronic vascular pulmonary dysplasia associated with neonatal hyperoxia exposure in the rat. Pediatr Res 21: 14-20, 1987.
41. Shannon J and Deterding R. Epithelial-mesenchymal interactions in lung development. In: Lung Growth and Development, edited by McDonald JA. New York: Dekker, 1997, p. 88-118.
42. Shaul PW, Afshar S, Gibson LL, Sherman TS, Kerecman JD, Grubb PH, Yoder BA, and McCurnin DC. Developmental changes in nitric oxide synthase isoform expression and nitric oxide production in fetal baboon lung. Am J Physiol Lung Cell Mol Physiol 283: L1192-L1199, 2002.
43. Shen B, Lee DY, and Zioncheck TF. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J Biol Chem 274: 33057-33063, 1999.
44. Sobonya RE, Logvinoff MM, Taussig LM, and Theriault A. Morphometric analysis of the lung in prolonged bronchopulmonary dysplasia. Pediatr Res 16: 969-972, 1982.
45. Stocker JT. Pathologic features of long-standing "healed" bronchopulmonary dysplasia: a study of 28 3- to 40-month-old infants. Hum Pathol 17: 943-961, 1986.
46. Tang JR, Le Cras TD, MorrisKGJr, and Abman SH. Brief perinatal hypoxia increases severity of pulmonary hypertension after reexposure to hypoxia in infant rats. Am J Physiol Lung Cell Mol Physiol 278: L356-L364, 2000.
47. Ten Have-Opbroek AA. Lung development in the mouse embryo. Exp Lung Res 17: 111-130, 1991.
48. Thibeault DW, Mabry SM, Ekekezie II, and Truog WE. Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease. Pediatrics 106: 1452-1459, 2000.
49. Thurlbeck WM. The internal surface area of nonemphysematous lungs. Am Rev Respir Dis 95: 765-773, 1967.
50. Thurlbeck WM. Measurement of pulmonary emphysema. Am Rev Respir Dis 95: 752-764, 1967.
51. Tschanz SA and Burri PH. A new approach to detect structural differences in lung parenchyma using digital image analysis. Exp Lung Res 28: 457-471, 2002.
52. Vernet D, Ferrini MG, Valente EG, Magee TR, Bou-Gharios G, Rajfer J, and Gonzalez-Cadavid NF. Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model. Nitric Oxide 7: 262-276, 2002.
53. Wang J, Morita I, Onodera M, and Murota SI. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide. J Cell Physiol 190: 238-250, 2002.
54. Warner BB, Stuart LA, Papes RA, and Wispe JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol Lung Cell Mol Physiol 275: L110-L117, 1998.
55. Wilborn AM, Evers LB, and Canada AT. Oxygen toxicity to the developing lung of the mouse: role of reactive oxygen species. Pediatr Res 40: 225-232, 1996.
56. Xu F, Fok TF, and Yin J. Hyperoxia-induced lung injury in premature rat: description of a suitable model for the study of lung diseases in newborns. Chin Med J (Engl) 111: 619-624, 1998.